Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?
Several hepatocellular carcinoma (HCC) staging systems have been established, and a variety of country-specific treatment strategies are also proposed. The barcelona - clinic liver cancer (BCLC) system is the most widely used in Europe. The Hong Kong liver Cancer is a new prognostic staging system;...
Gespeichert in:
Veröffentlicht in: | World journal of hepatology 2015-03, Vol.7 (3), p.521-531 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 531 |
---|---|
container_issue | 3 |
container_start_page | 521 |
container_title | World journal of hepatology |
container_volume | 7 |
creator | Adhoute, Xavier Penaranda, Guillaume Castellani, Paul Perrier, Herve Bourliere, Marc |
description | Several hepatocellular carcinoma (HCC) staging systems have been established, and a variety of country-specific treatment strategies are also proposed. The barcelona - clinic liver cancer (BCLC) system is the most widely used in Europe. The Hong Kong liver Cancer is a new prognostic staging system; it might become the reference system in Asia. Transarterial chemoembolization (TACE) is the most widely used treatment for HCC worldwide; but it showed a benefit only for intermediate stage HCC (BCLC B), and there is still no consensus concerning treatment methods and treatment strategies. In view of the highly diverse nature of HCC and practices, a scoring system designed to assist with decision making before the first TACE is performed or prior to repeating the procedure would be highly useful. |
doi_str_mv | 10.4254/wjh.v7.i3.521 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4381174</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1671214138</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-3385f49bcf8972905aad4fb9cb55c99a436ad1c5d750082cf832290308c37d963</originalsourceid><addsrcrecordid>eNpVkc9rFTEQx4MottQevUqOXva52SQviQdFir-gIIg9h2x2tpuySZ6Z3Vde_3rzbC11LjPDfPjODF9CXrN2Izop3t3eTJu92gS-kR17Rk6ZEbqRTHfPn9Qn5Bzxpq0hxNZo_ZKcdFILLZQ8JYef4HOMkAa3hJyQjrnQZQK6ItA8Uj9BzBD7PIe7vwQNie5qBWlBehuWiU5Q--xhntfZFepd8SHl6N7TK4RxnRMgHqXQ5xLSNcUDLhA_viIvRjcjnD_kM3L15fOvi2_N5Y-v3y8-XTaea7U0nGs5CtP7URvVmVY6N4ixN76X0hvjBN-6gXk5KNm2uqsY7yrGW-25GsyWn5EP97q7tY8w-Hp4cbPdlRBdOdjsgv1_ksJkr_PeCq4ZU6IKvH0QKPn3CrjYGPD4rkuQV7Rsq1jHBOO6os096ktGLDA-rmGtPTpmq2N2r2zgtjpW-TdPb3uk__nD_wCtwpZz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1671214138</pqid></control><display><type>article</type><title>Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?</title><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Adhoute, Xavier ; Penaranda, Guillaume ; Castellani, Paul ; Perrier, Herve ; Bourliere, Marc</creator><creatorcontrib>Adhoute, Xavier ; Penaranda, Guillaume ; Castellani, Paul ; Perrier, Herve ; Bourliere, Marc</creatorcontrib><description>Several hepatocellular carcinoma (HCC) staging systems have been established, and a variety of country-specific treatment strategies are also proposed. The barcelona - clinic liver cancer (BCLC) system is the most widely used in Europe. The Hong Kong liver Cancer is a new prognostic staging system; it might become the reference system in Asia. Transarterial chemoembolization (TACE) is the most widely used treatment for HCC worldwide; but it showed a benefit only for intermediate stage HCC (BCLC B), and there is still no consensus concerning treatment methods and treatment strategies. In view of the highly diverse nature of HCC and practices, a scoring system designed to assist with decision making before the first TACE is performed or prior to repeating the procedure would be highly useful.</description><identifier>ISSN: 1948-5182</identifier><identifier>EISSN: 1948-5182</identifier><identifier>DOI: 10.4254/wjh.v7.i3.521</identifier><identifier>PMID: 25848475</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Minireviews</subject><ispartof>World journal of hepatology, 2015-03, Vol.7 (3), p.521-531</ispartof><rights>The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-3385f49bcf8972905aad4fb9cb55c99a436ad1c5d750082cf832290308c37d963</citedby><cites>FETCH-LOGICAL-c387t-3385f49bcf8972905aad4fb9cb55c99a436ad1c5d750082cf832290308c37d963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381174/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381174/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25848475$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adhoute, Xavier</creatorcontrib><creatorcontrib>Penaranda, Guillaume</creatorcontrib><creatorcontrib>Castellani, Paul</creatorcontrib><creatorcontrib>Perrier, Herve</creatorcontrib><creatorcontrib>Bourliere, Marc</creatorcontrib><title>Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?</title><title>World journal of hepatology</title><addtitle>World J Hepatol</addtitle><description>Several hepatocellular carcinoma (HCC) staging systems have been established, and a variety of country-specific treatment strategies are also proposed. The barcelona - clinic liver cancer (BCLC) system is the most widely used in Europe. The Hong Kong liver Cancer is a new prognostic staging system; it might become the reference system in Asia. Transarterial chemoembolization (TACE) is the most widely used treatment for HCC worldwide; but it showed a benefit only for intermediate stage HCC (BCLC B), and there is still no consensus concerning treatment methods and treatment strategies. In view of the highly diverse nature of HCC and practices, a scoring system designed to assist with decision making before the first TACE is performed or prior to repeating the procedure would be highly useful.</description><subject>Minireviews</subject><issn>1948-5182</issn><issn>1948-5182</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVkc9rFTEQx4MottQevUqOXva52SQviQdFir-gIIg9h2x2tpuySZ6Z3Vde_3rzbC11LjPDfPjODF9CXrN2Izop3t3eTJu92gS-kR17Rk6ZEbqRTHfPn9Qn5Bzxpq0hxNZo_ZKcdFILLZQ8JYef4HOMkAa3hJyQjrnQZQK6ItA8Uj9BzBD7PIe7vwQNie5qBWlBehuWiU5Q--xhntfZFepd8SHl6N7TK4RxnRMgHqXQ5xLSNcUDLhA_viIvRjcjnD_kM3L15fOvi2_N5Y-v3y8-XTaea7U0nGs5CtP7URvVmVY6N4ixN76X0hvjBN-6gXk5KNm2uqsY7yrGW-25GsyWn5EP97q7tY8w-Hp4cbPdlRBdOdjsgv1_ksJkr_PeCq4ZU6IKvH0QKPn3CrjYGPD4rkuQV7Rsq1jHBOO6os096ktGLDA-rmGtPTpmq2N2r2zgtjpW-TdPb3uk__nD_wCtwpZz</recordid><startdate>20150327</startdate><enddate>20150327</enddate><creator>Adhoute, Xavier</creator><creator>Penaranda, Guillaume</creator><creator>Castellani, Paul</creator><creator>Perrier, Herve</creator><creator>Bourliere, Marc</creator><general>Baishideng Publishing Group Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150327</creationdate><title>Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?</title><author>Adhoute, Xavier ; Penaranda, Guillaume ; Castellani, Paul ; Perrier, Herve ; Bourliere, Marc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-3385f49bcf8972905aad4fb9cb55c99a436ad1c5d750082cf832290308c37d963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Minireviews</topic><toplevel>online_resources</toplevel><creatorcontrib>Adhoute, Xavier</creatorcontrib><creatorcontrib>Penaranda, Guillaume</creatorcontrib><creatorcontrib>Castellani, Paul</creatorcontrib><creatorcontrib>Perrier, Herve</creatorcontrib><creatorcontrib>Bourliere, Marc</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adhoute, Xavier</au><au>Penaranda, Guillaume</au><au>Castellani, Paul</au><au>Perrier, Herve</au><au>Bourliere, Marc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?</atitle><jtitle>World journal of hepatology</jtitle><addtitle>World J Hepatol</addtitle><date>2015-03-27</date><risdate>2015</risdate><volume>7</volume><issue>3</issue><spage>521</spage><epage>531</epage><pages>521-531</pages><issn>1948-5182</issn><eissn>1948-5182</eissn><abstract>Several hepatocellular carcinoma (HCC) staging systems have been established, and a variety of country-specific treatment strategies are also proposed. The barcelona - clinic liver cancer (BCLC) system is the most widely used in Europe. The Hong Kong liver Cancer is a new prognostic staging system; it might become the reference system in Asia. Transarterial chemoembolization (TACE) is the most widely used treatment for HCC worldwide; but it showed a benefit only for intermediate stage HCC (BCLC B), and there is still no consensus concerning treatment methods and treatment strategies. In view of the highly diverse nature of HCC and practices, a scoring system designed to assist with decision making before the first TACE is performed or prior to repeating the procedure would be highly useful.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>25848475</pmid><doi>10.4254/wjh.v7.i3.521</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1948-5182 |
ispartof | World journal of hepatology, 2015-03, Vol.7 (3), p.521-531 |
issn | 1948-5182 1948-5182 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4381174 |
source | Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Minireviews |
title | Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T03%3A04%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recommendations%20for%20the%20use%20of%20chemoembolization%20in%20patients%20with%20hepatocellular%20carcinoma:%20Usefulness%20of%20scoring%20system?&rft.jtitle=World%20journal%20of%20hepatology&rft.au=Adhoute,%20Xavier&rft.date=2015-03-27&rft.volume=7&rft.issue=3&rft.spage=521&rft.epage=531&rft.pages=521-531&rft.issn=1948-5182&rft.eissn=1948-5182&rft_id=info:doi/10.4254/wjh.v7.i3.521&rft_dat=%3Cproquest_pubme%3E1671214138%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1671214138&rft_id=info:pmid/25848475&rfr_iscdi=true |